BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 21785401)

  • 1. Superimposed linear psoriasis: low effectiveness of biologic therapy.
    Colombo L; Marconi M; Mapelli ET; Crespi E; Gualandri L; Menni S; Cerri A
    G Ital Dermatol Venereol; 2011 Aug; 146(4):311-3. PubMed ID: 21785401
    [No Abstract]   [Full Text] [Related]  

  • 2. [Psoriasis and psoriatic rheumatism: effectiveness of etanercept for cutaneous and joint lesions].
    Paul C; Solignac M
    Ann Dermatol Venereol; 2010 Apr; 137(4 Suppl):13-5. PubMed ID: 20510165
    [No Abstract]   [Full Text] [Related]  

  • 3. TNFalpha therapy in psoriatic arthritis and psoriasis.
    Mease P
    Ann Rheum Dis; 2004 Jul; 63(7):755-8. PubMed ID: 15194567
    [No Abstract]   [Full Text] [Related]  

  • 4. Etanercept monotherapy for a patient with psoriasis, psoriatic arthritis, and concomitant hepatitis C infection.
    Rokhsar C; Rabhan N; Cohen SR
    J Am Acad Dermatol; 2006 Feb; 54(2):361-2. PubMed ID: 16443079
    [No Abstract]   [Full Text] [Related]  

  • 5. Combination biologic treatment of refractory psoriasis and psoriatic arthritis.
    Cuchacovich R; Garcia-Valladares I; Espinoza LR
    J Rheumatol; 2012 Jan; 39(1):187-93. PubMed ID: 22210681
    [No Abstract]   [Full Text] [Related]  

  • 6. Biologic therapy in psoriatic arthritis mutilans.
    Peixoto D; Teixeira F; Bogas M; Costa J; Araújo D
    Acta Reumatol Port; 2011; 36(2):189-90. PubMed ID: 21841743
    [No Abstract]   [Full Text] [Related]  

  • 7. The treatment of psoriasis and psoriatic arthritis: an interdisciplinary approach.
    Gordon KB; Ruderman EM
    J Am Acad Dermatol; 2006 Mar; 54(3 Suppl 2):S85-91. PubMed ID: 16488334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-tumor necrosis factor alpha therapy in psoriatic arthritis and psoriasis.
    Girolomoni G; Abeni D
    Arch Dermatol; 2001 Jun; 137(6):784-5. PubMed ID: 11405771
    [No Abstract]   [Full Text] [Related]  

  • 9. [Therapy of psoriasis vulgaris and psoriatic arthritis with etanercept].
    Mrowietz U; Barth J; Boehncke WH; Rosenbach T; Wozel G
    J Dtsch Dermatol Ges; 2005 Jun; 3(6):470-2. PubMed ID: 15892851
    [No Abstract]   [Full Text] [Related]  

  • 10. Etanercept for the treatment of psoriasis: combination therapy with other modalities.
    Strober BE; Clarke S
    J Drugs Dermatol; 2004; 3(3):270-2. PubMed ID: 15176161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Etanercept plus ciclosporin versus etanercept plus methotrexate for maintaining clinical control over psoriatic arthritis: a randomised pilot study.
    Atzeni F; Boccassini L; Antivalle M; Salaffi F; Sarzi-Puttini P
    Ann Rheum Dis; 2011 Apr; 70(4):712-4. PubMed ID: 20810394
    [No Abstract]   [Full Text] [Related]  

  • 12. Combination of skin, joint and quality of life outcomes with etanercept in psoriasis and psoriatic arthritis in the PRESTA trial.
    Prinz JC; Fitzgerald O; Boggs RI; Foehl J; Robertson D; Pedersen R; Molta CT; Freundlich B
    J Eur Acad Dermatol Venereol; 2011 May; 25(5):559-64. PubMed ID: 20840349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generalised pustular psoriasis induced by cyclosporin a withdrawal responding to the tumour necrosis factor alpha inhibitor etanercept.
    Kamarashev J; Lor P; Forster A; Heinzerling L; Burg G; Nestle FO
    Dermatology; 2002; 205(2):213-6. PubMed ID: 12218252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paradoxical reaction to etanercept: development of pyoderma gangraenosum during therapy of psoriasis arthritis.
    Kowalzick L; Bertolini J; Baumann C; Walther B; Truhm B; Eickenscheidt L
    J Dtsch Dermatol Ges; 2013 May; 11(5):447-9. PubMed ID: 23343137
    [No Abstract]   [Full Text] [Related]  

  • 15. Successful treatment with etanercept of von Zumbusch pustular psoriasis in a patient with human immunodeficiency virus.
    Mikhail M; Weinberg JM; Smith BL
    Arch Dermatol; 2008 Apr; 144(4):453-6. PubMed ID: 18427038
    [No Abstract]   [Full Text] [Related]  

  • 16. Combination therapy with ciclosporin and etanercept in patients with psoriatic arthritis.
    D'Angelo S; Cutro MS; Lubrano E; Leccese P; Mennillo GA; Ferrara N; Olivieri I
    Ann Rheum Dis; 2010 May; 69(5):934-5. PubMed ID: 19666936
    [No Abstract]   [Full Text] [Related]  

  • 17. Life-table analysis of etanercept with or without methotrexate in patients with psoriatic arthritis.
    Spadaro A; Ceccarelli F; Scrivo R; Valesini G
    Ann Rheum Dis; 2008 Nov; 67(11):1650-1. PubMed ID: 18854519
    [No Abstract]   [Full Text] [Related]  

  • 18. Palmoplantar pustulosis with arthro-osteitis: successful treatment with etanercept and acitretin.
    Antoniou C; Nicolaidou E; Moustou AE; Stratigos A; Katsambas A
    J Eur Acad Dermatol Venereol; 2009 Jul; 23(7):854-5. PubMed ID: 19646137
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy and safety of etanercept in psoriasis after switching from other treatments: an observational study.
    Mazzotta A; Esposito M; Costanzo A; Chimenti S
    Am J Clin Dermatol; 2009; 10(5):319-24. PubMed ID: 19658444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Follow-up of psoriatic arthritis mutilans patients treated with anti-TNF-alpha therapy.
    Pomerantz RG; Mody E; Husni ME; Qureshi AA
    J Drugs Dermatol; 2009 Apr; 8(4):406-12. PubMed ID: 19363860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.